Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
Browsing: Neurodegenerative Disease Management
A study from Neurodegenerative Disease Management explores the lack of understanding around juvenile Huntington’s disease and its symptoms.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.
Difficulty in turning in bed is rated as the most troublesome night-time symptom among Parkinson’s patients – this study aims to develop a practival objective method for home assessment of a patient’s ability to turn in bed.
This Review from Neurodegenerative Disease Management explores light therapy for Alzheimer’s disease and related dementias, and how to maximize treatment impact.
Jutley et al. discuss established glaucoma treatments, review promising new neuroprotective agents, and explore potential future treatments targeting the neurodenegerative processes in glaucoma.
Amyloid positron emission tomography (aPET) measurement of Alzheimer’s disease (AD) pathology could improve the accurate diagnosis of cognitive disorders.
In this review, the authors discuss the history of DBS for Parkinson’s disease, as well as outcomes, recent advances, and where the field will go next.
In this review the authors explore an individualized approach to managing cognitive impairment in progressive supranuclear palsy.